Ftse Mib
33.816,58
-0,48%
DAX
19.215,48
-0,79%
S&P 500
5.995,54
0,38%
NASDAQ
19.286,78
0,09%
Bitcoin
76.347,85
-0,29%
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Windtree Therapeutics Inc (WINT) Windtree Therapeutics Inc (WINT) Notizie

Windtree Therapeutics Inc

WINT
0,5789
-0,0318 (-5,21%)
09 Nov 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
04/11/202414:00GLOBEWindtree Announces Expansion of Patents with Issuance of..
30/10/202413:00GLOBEWindtree Therapeutics Initiates SEISMiC C Study of..
23/10/202414:00GLOBEWindtree Announces Istaroxime Cardiogenic Shock Patent..
21/10/202414:00GLOBEWindtree To Present at the ThinkEquity Conference on October..
17/10/202414:15GLOBEWindtree Announces Expansion of Patents with Issuance of..
09/10/202414:00GLOBEWindtree Announces Publication of Positive Istaroxime Phase..
09/10/202413:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/9/202414:15GLOBEWindtree Announces Positive Phase 2b Topline Clinical..
26/9/202422:05GLOBEWindtree Therapeutics Announces Virtual Investor Day..
25/9/202414:15GLOBEWindtree Announces Positive Topline Results from Its Phase..
25/9/202414:05EDGAR2Form 8-K - Current report
24/9/202423:21EDGAR2Form 8-K - Current report
04/9/202414:00GLOBEWindtree Completes Enrollment of Phase 2b Study of..
04/9/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
03/9/202415:10EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
03/9/202415:09EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
03/9/202413:22EDGAR2Form DEF 14A - Other definitive proxy statements
23/8/202422:15EDGAR2Form S-1 - General form for registration of securities under..
21/8/202422:55EDGAR2Form S-3 - Registration statement under Securities Act of..
20/8/202422:30EDGAR2Form 8-K - Current report
20/8/202422:05GLOBEWindtree Therapeutics Reports Second Quarter 2024 Financial..
19/8/202423:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/8/202422:24EDGAR2Form 3 - Initial statement of beneficial ownership of..
14/8/202422:20EDGAR2Form 3 - Initial statement of beneficial ownership of..
14/8/202422:13EDGAR2Form 8-K - Current report
14/8/202422:11EDGAR2Form NT 10-Q - Notification of inability to timely file Form..
14/8/202422:05GLOBEWindtree Announces New Additions and Changes to Its Board of..
29/7/202414:33EDGAR2Form 8-K - Current report
25/7/202422:07EDGAR2Form RW - Registration Withdrawal Request
25/7/202414:00GLOBEWindtree Therapeutics Provides Update on Istaroxime Clinical..
24/7/202423:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/7/202423:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/7/202422:05GLOBEWindtree Therapeutics Announces Closing of Financing Through..
22/7/202415:25EDGAR2Form 8-K - Current report
10/7/202422:53EDGAR2Form 8-K - Current report
15/5/202422:59EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/5/202414:41EDGAR2Form S-1 - General form for registration of securities under..
07/5/202414:00GLOBEWindtree Therapeutics Regains Compliance with Nasdaq
18/4/202414:00GLOBEWindtree Therapeutics Announces Reverse Stock Split
17/4/202414:00GLOBEWindtree Therapeutics Reports Fourth Quarter and Year-End..
08/4/202422:48GLOBEWindtree Acquires Early-Stage, Novel Oncology Platform and..
16/2/202423:07EDGAR2Form 8-K - Current report
14/2/202423:23EDGAR2Form S-3 - Registration statement under Securities Act of..
14/2/202422:30EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202402:15EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
12/2/202422:40EDGAR2Form PRE 14A - Other preliminary proxy statements
01/2/202423:26EDGAR2Form SC 13G - Statement of acquisition of beneficial..
01/2/202414:00GLOBEWindtree Renews Agreement with Chang Gung University for..
31/1/202414:40IHNWWindtree Therapeutics Announces Engagement of Strategic..
31/1/202414:00EDGAR2Form 8-K - Current report
Apertura: 0,6198 Min: 0,53 Max: 0,6198
Chiusura: 0,6107

La tua Cronologia

NASDAQ
WINT
Windtree Therapeutics
LSE
0A5P
House Of Control Group As
LSE
PW01
Bk. Queen 29
USOTC
PLPL
Plandai Biotechnology (PK)
TSX
PSK
PrairieSky Royalty
COIN
XDCUSD
XinFin Development Contract
LSE
MKS
Marks And Spencer
LSE
70YT
Bank Mont. 30
LSE
0QU1
Prime Car Management
BIT
F39260
Vontobel Financial Produ...
LSE
DBOX
Digitalbox
NYSE
TJX
TJX Companies
KOSDAQ
159910
MBK
LSE
0QV2
Bactiguard Holding Ab
ASX
MWR
Spacetalk
AMEX
JHDV
John Hancock Us High Div...
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network